Sionna Therapeutics SION
NASDAQ SION
$3.70 +0.13 (+3.64%)
As of: Nov 10, 2026 · 3:59 PM EST

Sionna Therapeutics (SION) Operating Leases (2024 - 2026)

Updated

Sionna Therapeutics (SION) recorded Operating Leases of $6.69 million in Q2 2026, down 17.1% from $8.07 million a year earlier and down 5.1% from the prior quarter.

Analysis

Sionna Therapeutics (SION) Operating Leases (2024 - 2026) Analysis & Trends

At the end of FY2025, Sionna Therapeutics reported Operating Leases of $7.41 million, down 14.6% from FY2024.

  • Across earlier years, Operating Leases came in at $8.68 million in FY2024.
  • On a year-over-year basis, Operating Leases has declined for three consecutive quarters.
  • Per Business Quant, the preceding three quarters came in at $7.06 million (Q1 2026), $7.41 million (Q4 2025) and $7.75 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Sionna Therapeutics 166.37 Mn -745.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.69 Mn
Mar 31, 2026 7.06 Mn
Dec 31, 2025 7.41 Mn
Sep 30, 2025 7.75 Mn
Jun 30, 2025 8.07 Mn
Mar 31, 2025 8.38 Mn
Dec 31, 2024 8.68 Mn
API Access

Sionna Therapeutics Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=SION&period=max&api_key=YOUR_API_KEY